title: Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy.
authors.affiliation: Department of Internal Medicine, University Hospital Utrecht, Netherlands.
authors.forename: B
authors.initials: B
authors.lastname: Bravenboer
authors.forename: D W
authors.initials: DW
authors.lastname: Erkelens
authors.forename: W H
authors.initials: WH
authors.lastname: Gispen
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use*; D002945:Cisplatin / Q000009:adverse effects; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use*
chemical_list: D000927:Anticonvulsants; D010446:Peptide Fragments; C013765:Org 2766; D000324:Adrenocorticotropic Hormone; D002945:Cisplatin